morning all,
I will reply to 18041970 on this thread because it is more relevant than in a charting thread.
Re. the news ann. - this is at bare minimum confirmation that the company thinks that it is worth running with for another year - it could also mean that they are excited about it --------- only time will tell.
"What MedAdvisor appears to do quite well, is simply medication management."
Actually - it does it more than quite well from what I see - it does it very well.
"Competition, especially in the "Consumer App" space is always something I am wary of with these...."
Competition in the app. space is a constant --------- but, apps. are no different to any other business - an app. is really only the front end ------------ 'everything' behind it has to work and work well and integrate well for an app. or a business to perform well ----------- which, makes the 'app. competition' thing - fairly minor in reality.
That the app. needs to be good - yes, is crucial - but, a perfect app. is not worth a cent - if pharmacies don't get behind it or people don't use it.
It is pretty clear that this app. has that happening - and, yes, there is 'some' resistance in some quarters - but, there always are resistant quarters in technological change. I worked for a while in a Govt' department where the 'boss' resisted going to email from snail mail ------------- can you believe such a dinosaur act? -- Of course - eventually - and rapidly - the dinosaur was swept away in the rush of the tide of progress.
So - if this thing continues - most will change to it --------- bar perhaps the very old - who aren't into technology.
The big possible resistors in this are the doctors etc. -- they are dinosaurs - still, many records on paper - still some are handwriting - and, still many 2 fingered typists among them.
But, - the tide will sweep them away very very rapidly as well - it won't be MDR that will do it by itself --- AI is coming like a train - robot surgery is here - and digital records are here - and, none will survive if they don't convert.
The only questions for MDR are -- is the timing right? and can the company get the revenue they want from what areas they want - and, what other revenue areas will open up?
One thing in this world that works is money. It may well be the root of all evil - but, it is in fact the biggest driver of all (broadly) - if there is enough money to be made or enough money to be saved - AND it can be demonstrated - with little outlay or risk - then people will go for it ------------ even the medical profession.
Medication is a really really big deal in life ----------------- inappropriate medication is one of the biggest killers and injurers in our society - it is also one of the biggest costs - it is also one of the biggest areas of waste.
ANY company that can come in and hit this space with a money saving and/or making idea that runs - WILL do well - very well - it's that simple.
"Big risks, still not going to be profitable for a while yet (although the actual, existing revenue is a nice change from many others) so its far from a sure thing. I'm in for a punt, grabbed a few more today.. if this does a RAP, I don't want to miss it but not under any illusions that its a sure-thing."
Agree with the above ----------- there are just not enough runs on the board yet - and, in my case, not enough known about the team and team dynamic yet to make a high conviction buy - but, at the stage it is at -- IMO - it's worth a reasonable punt - and, if it comes off - it will pay handsomely. If it doesn't - then, I think it will be a low risk - or at least low loss punt/investment.
We shall see.
have a great day all.
- Forums
- ASX - By Stock
- MDR
- Ann: GlaxoSmithKline Extends Service Agreement with MedAdvisor-MDR.AX
Ann: GlaxoSmithKline Extends Service Agreement with MedAdvisor-MDR.AX, page-8
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDR (ASX) to my watchlist
|
|||||
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $253.6M |
Open | High | Low | Value | Volume |
46.0¢ | 46.0¢ | 46.0¢ | $5.601K | 12.17K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 18152 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.0¢ | 4307 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 18152 | 0.450 |
5 | 110071 | 0.445 |
2 | 15252 | 0.435 |
3 | 15878 | 0.430 |
4 | 104839 | 0.425 |
Price($) | Vol. | No. |
---|---|---|
0.460 | 4307 | 1 |
0.465 | 22632 | 2 |
0.470 | 11104 | 1 |
0.475 | 21444 | 2 |
0.480 | 18857 | 4 |
Last trade - 11.38am 23/08/2024 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online